In contrast, the tumor from patient #7360 (Fig. 7D–F) had prior to treatment mainly HER2+/ER− cells, but the biopsy after treatment and from the metastasis revealed a small fraction of HER2−/ER− cells. Here, ERBB2 is linked to neoplasm.